The International Journal of Clinical Oncology (IJCO) is a highly regarded publication dedicated to advancing clinical oncology through the dissemination of cutting-edge research and evidence-based practices. The journal provides a platform for oncologists, surgeons, radiation oncologists, and other healthcare professionals to share their expertise and insights on the diagnosis, treatment, and prevention of cancer. It covers various aspects of clinical oncology, cancer research, clinical trials, and nuclear medicine.
IJCO focuses on patient care and improving outcomes for individuals affected by cancer. Key areas include surgical oncology, radiation oncology, medical oncology, and palliative care. The journal also highlights innovative approaches to cancer management, such as targeted therapy, immunotherapy, and precision medicine. With a global perspective, IJCO targets a broad audience, including researchers, clinicians, and policymakers dedicated to advancing cancer care worldwide. It's especially helpful in prevention and diagnosis.
IJCO aims to bridge the gap between basic science and clinical practice, facilitating the translation of research findings into improved patient care. By publishing high-quality, peer-reviewed articles, the journal serves as an essential resource for healthcare professionals seeking to stay at the forefront of clinical oncology and oncology education. Authors are encouraged to submit innovative studies related to gastric cancer and other types of cancer.